TherapeuticsMD Inc reports results for the quarter ended in September - Earnings Summary

TherapeuticsMD

14/11/2022 21:52

* TherapeuticsMD Inc  TXMD.OQ  reported a quarterly adjusted
loss
of $3.13​​ per share for the quarter ended in September. The
lone analyst forecast for the quarter was for a loss of 57 cents
per share.
    * Revenue fell 17.7% to $20.92 million from a year ago;
analysts
expected $26.80 million. 
    * TherapeuticsMD Inc's reported EPS for the quarter was a
loss of
$3.13​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * TherapeuticsMD Inc shares had risen by 5.1% this
quarter and
lost 60.7% so far this year.
    * The company reported a quarterly loss of $28.97 million.
    * Wall Street's median 12-month price target for
TherapeuticsMD
Inc is $65.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 09:52 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.57          -3.13          Missed
 Jun. 30 2022      -3.04          12.39          Beat
 Mar. 31 2022      -4.00          -5.69          Missed
 Dec. 31 2021      -3.83          -5.00          Missed